BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

TEVA PHARMACEUTICALS USA, INC. — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

TEVA PHARMACEUTICALS USA, INC.

via GARY BUEHLER

2nd Quarter (Apr 1 - June 30) · 2015Posted Jul 13, 2015Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: TEVA PHARMACEUTICALS USA, INC.
Description: Pharmaceutical Research and Manufacturing
Location: District of Columbia · United States of America

Registrant

Firm: GARY BUEHLER
Description: Consultant
Location: Lansdale, Pennsylvania, United States of America

Lobbying activities

1 issue

Pharmacy
Section 505(b)(2) new drug applications and exclusivity period.
LobbyistsGARY BUEHLER
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.